// App-Quantinova.ai

5016 : Hearing loss after cisplatin-based chemotherapy: Patient-reported outcomes versus audiometric assessments.

Researchers

Presenter

  • Shirin Ardeshirrouhanifard

Principal Investigators

  • Sophie Foss

  • Robert A Huddart

  • Patrick O. Monahan

  • Chunkit Fung

  • Yiqing Song

  • M. Eileen Dolan

  • Darren R. Feldman

  • Robert James Hamilton

  • David J. Vaughn

  • Neil E. Martin

  • Christian K. Kollmannsberger

  • Paul C Dinh

  • Lifang Hou

  • Yinan Zheng

  • Lawrence Einhorn

  • Robert D. Frisina

  • Lois B. Travis

Medical Centers

  • Indiana University School of Medicine, Indianapolis, IN

  • National Advisory Unit on Late Effects After Cancer Treatment, Oslo, Norway

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • James P. Wilmot Cancer Institute, University of Rochester Medical Center,

  • Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN.

  • Department of Radiology, University of Chicago, Chicago, IL

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Division of Gynecologic Oncology, Princess Margaret Cancer Centre/University Health Network/Sinai Health Systems, Toronto, ON, Canada

  • Department of Medicine, University of Pennsylvania, Philadelphia, PA

  • Dana-Farber Cancer Institute, Boston, MA

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Feinberg School of Medicine, Northwestern University, Chicago, IL

  • Northwestern University, Chicago, IL

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Departments of Medical Engineering and Communication Sciences and Disorders, Global Center for Hearing and Speech Research, University of South Florida, Tampa, FL

Locations

  • United States

  • Norway

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Testicular cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A